Annual Interest Expense
$1.22 M
-$31.20 K-2.49%
December 31, 2023
Summary
- As of February 8, 2025, INO annual interest expense is $1.22 million, with the most recent change of -$31.20 thousand (-2.49%) on December 31, 2023.
- During the last 3 years, INO annual interest expense has fallen by -$7.48 million (-85.95%).
- INO annual interest expense is now -85.95% below its all-time high of $8.70 million, reached on December 31, 2020.
Performance
INO Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, INO quarterly interest expense is $0.00, unchanged on September 30, 2024.
- Over the past year, INO quarterly interest expense has dropped by -$282.30 thousand (-100.00%).
- INO quarterly interest expense is now -100.00% below its all-time high of $2.85 million, reached on June 30, 2020.
Performance
INO Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Interest Expense
$460.10 K
-$313.50 K-40.52%
September 30, 2024
Summary
- As of February 8, 2025, INO TTM interest expense is $460.10 thousand, with the most recent change of -$313.50 thousand (-40.52%) on September 30, 2024.
- Over the past year, INO TTM interest expense has dropped by -$762.70 thousand (-62.37%).
- INO TTM interest expense is now -95.72% below its all-time high of $10.75 million, reached on June 30, 2020.
Performance
INO TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
INO Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2.5% | -100.0% | -62.4% |
| 3 y3 years | -86.0% | -100.0% | -71.0% |
| 5 y5 years | +100.0% | -100.0% | -71.0% |
INO Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.9% | at low | -100.0% | at low | -76.2% | at low |
| 5 y | 5-year | -86.0% | at low | -100.0% | at low | -95.7% | at low |
| alltime | all time | -86.0% | -100.0% | -100.0% | at low | -95.7% | -100.0% |
Inovio Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $460.10 K(-40.5%) |
| Jun 2024 | - | $0.00(-100.0%) | $773.60 K(-28.8%) |
| Mar 2024 | - | $177.80 K(-37.0%) | $1.09 M(-11.1%) |
| Dec 2023 | $1.22 M(-2.5%) | $282.30 K(-10.0%) | $1.22 M(-2.5%) |
| Sep 2023 | - | $313.50 K(0.0%) | $1.25 M(0.0%) |
| Jun 2023 | - | $313.50 K(0.0%) | $1.25 M(0.0%) |
| Mar 2023 | - | $313.50 K(0.0%) | $1.25 M(0.0%) |
| Dec 2022 | $1.25 M(-35.2%) | $313.50 K(0.0%) | $1.25 M(-11.7%) |
| Sep 2022 | - | $313.50 K(0.0%) | $1.42 M(-10.3%) |
| Jun 2022 | - | $313.50 K(0.0%) | $1.58 M(-8.8%) |
| Mar 2022 | - | $313.50 K(-34.7%) | $1.74 M(-10.3%) |
| Dec 2021 | $1.94 M | $480.30 K(+0.8%) | $1.94 M(-23.3%) |
| Sep 2021 | - | $476.40 K(+2.1%) | $2.52 M(-37.4%) |
| Jun 2021 | - | $466.70 K(-9.0%) | $4.03 M(-37.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $513.00 K(-52.0%) | $6.41 M(-26.3%) |
| Dec 2020 | $8.70 M(+9.5%) | $1.07 M(-46.2%) | $8.70 M(-15.5%) |
| Sep 2020 | - | $1.98 M(-30.3%) | $10.30 M(-4.1%) |
| Jun 2020 | - | $2.85 M(+1.5%) | $10.75 M(+6.5%) |
| Mar 2020 | - | $2.80 M(+5.1%) | $10.10 M(+27.0%) |
| Dec 2019 | $7.95 M(>+9900.0%) | $2.67 M(+9.9%) | $7.95 M(+50.5%) |
| Sep 2019 | - | $2.43 M(+10.7%) | $5.28 M(+85.2%) |
| Jun 2019 | - | $2.19 M(+234.5%) | $2.85 M(+334.5%) |
| Mar 2019 | - | $656.20 K(>+9900.0%) | $656.20 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $25.90 K(+379.6%) | - | - |
| Dec 2002 | $5400.00(-49.5%) | - | - |
| Dec 2001 | $10.70 K | - | - |
FAQ
- What is Inovio Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals annual interest expense year-on-year change?
- What is Inovio Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals quarterly interest expense year-on-year change?
- What is Inovio Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Inovio Pharmaceuticals?
- What is Inovio Pharmaceuticals TTM interest expense year-on-year change?
What is Inovio Pharmaceuticals annual interest expense?
The current annual interest expense of INO is $1.22 M
What is the all time high annual interest expense for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high annual interest expense is $8.70 M
What is Inovio Pharmaceuticals annual interest expense year-on-year change?
Over the past year, INO annual interest expense has changed by -$31.20 K (-2.49%)
What is Inovio Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of INO is $0.00
What is the all time high quarterly interest expense for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high quarterly interest expense is $2.85 M
What is Inovio Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, INO quarterly interest expense has changed by -$282.30 K (-100.00%)
What is Inovio Pharmaceuticals TTM interest expense?
The current TTM interest expense of INO is $460.10 K
What is the all time high TTM interest expense for Inovio Pharmaceuticals?
Inovio Pharmaceuticals all-time high TTM interest expense is $10.75 M
What is Inovio Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, INO TTM interest expense has changed by -$762.70 K (-62.37%)